Bottom line
PCEXX vs ESPTX: the short answer
PCEXX (UBS Government Money Market Investments Fund) and ESPTX (UBS International Sustainable Equity Fund) are both money market funds.
PCEXX is cheaper at 0.16% vs 0.26% — a difference of $10.00 a year per $10,000 invested.
Over five years, ESPTX returned +7.9% a year vs +2.3% for PCEXX (reporting dates differ).
Updated Nov 19, 2026
PCEXX vs ESPTX side by side
| PCEXX | ESPTX | |
|---|---|---|
| Type | Money market fund | Mutual fund |
| Fund family | Pace Select Advisors | Ubs |
| Category | Money Market | International Stock |
| Expense ratio | 0.16% | 0.26% |
| Annual cost per $10k | $16 | $26 |
| 10-yr cost on $10k (prospectus) | $355 | $1,434 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +5.2% | +30.2% |
| 5-yr return (annualized) | +2.3% | +7.9% |
| 10-yr return (annualized) | +1.5% | — |
| Best quarter | +1.3% | +17.8% |
| Worst quarter | 0.0% | −22.6% |
| Net assets (fund) | — | $119.9M |
| Number of holdings | — | 65 |
| Portfolio turnover | — | 31% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PCEXX | ESPTX | Difference |
|---|---|---|---|
| 2024 | +5.2% | +7.4% | −2.2% |
| 2023 | +5.0% | +16.2% | −11.2% |
| 2022 | +1.2% | −13.4% | +14.6% |
| 2021 | +0.0% | +4.1% | −4.1% |
Source: Fund prospectus bar charts
Holdings overlap
PCEXX and ESPTX share none of their top holdings.
PCEXX top 10
ESPTX top 10
- State Street Global Advisors — 6.75%
- ASML Holding NV — 4.00%
- Banco Bilbao Vizcaya Argentaria SA — 2.99%
- Mitsubishi UFJ Financial Group Inc — 2.97%
- AIB Group PLC — 2.71%
- AstraZeneca PLC — 2.69%
- Infineon Technologies AG — 2.67%
- Sony Group Corp — 2.38%
- State Street Global Advisors — 2.35%
- Legal & General Group PLC — 2.17%
FAQ
What is the difference between PCEXX and ESPTX?
Which is cheaper, PCEXX or ESPTX?
Should I own both PCEXX and ESPTX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.